Cargando…

Combining bevacizumab and chemoradiation in rectal cancer. Translational results of the AXEBeam trial

BACKGROUND: This study characterises molecular effect of bevacizumab, and explores the relation of molecular and genetic markers with response to bevacizumab combined with chemoradiotherapy (CRT). METHODS: From a subset of 59 patients of 84 rectal cancer patients included in a phase II study combini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Verstraete, M, Debucquoy, A, Dekervel, J, van Pelt, J, Verslype, C, Devos, E, Chiritescu, G, Dumon, K, D'Hoore, A, Gevaert, O, Sagaert, X, Van Cutsem, E, Haustermans, K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2015
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4402460/ https://www.ncbi.nlm.nih.gov/pubmed/25867261 http://dx.doi.org/10.1038/bjc.2015.93

Ejemplares similares

Nonoperative versus operative approach according to the response to neoadjuvant chemoradiotherapy for rectal cancer: A prospective cohort study
por: Bulens, Philippe P., et al.
Publicado: (2022)

Development of a Patient Decision Aid for Rectal Cancer Patients with Clinical Complete Response after Neo-Adjuvant Treatment
por: Smets, Lien, et al.
Publicado: (2023)

Health-related quality of life in rectal cancer: a topic more relevant now than ever
por: Wolthuis, Albert M, et al.
Publicado: (2022)

In vitro and in vivo evaluation of the radiosensitizing effect of a selective FGFR inhibitor (JNJ-42756493) for rectal cancer
por: Verstraete, Maud, et al.
Publicado: (2015)

Acriflavine Inhibits Acquired Drug Resistance by Blocking the Epithelial-to-Mesenchymal Transition and the Unfolded Protein Response
por: Dekervel, Jeroen, et al.
Publicado: (2016)

Anti-Cancer Activity of Acriflavine as Metabolic Inhibitor of OXPHOS in Pancreas Cancer Xenografts
por: Bulle, Ashenafi, et al.
Publicado: (2020)

Unraveling the Synergy between Atezolizumab and Bevacizumab for the Treatment of Hepatocellular Carcinoma
por: Brackenier, Cedric, et al.
Publicado: (2023)

Readmission after rectal resection in the ERAS-era: is a loop ileostomy the Achilles heel?
por: Van Butsele, Johanna, et al.
Publicado: (2021)

Controversy in the treatment of symptomatic internal rectal prolapse: suspension or resection?
por: Festen, S., et al.
Publicado: (2010)

DNA methylation-driven EMT is a common mechanism of resistance to various therapeutic agents in cancer
por: Galle, Eva, et al.
Publicado: (2020)

Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer
por: Bulle, Ashenafi, et al.
Publicado: (2020)

A Global Risk Score (GRS) to Simultaneously Predict Early and Late Tumor Recurrence Risk after Resection of Hepatocellular Carcinoma()
por: Dekervel, Jeroen, et al.
Publicado: (2016)

Survival among rectal cancer patients in Belgium receiving different preoperative and postoperative treatment: a population-based comparison
por: Silversmit, Geert, et al.
Publicado: (2015)

A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system
por: Coolbrandt, A., et al.
Publicado: (2023)

PD-1(-) CD45RA(+) effector-memory CD8 T cells and CXCL10(+) macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma
por: Cappuyns, Sarah, et al.
Publicado: (2023)

Peptide Receptor Radionuclide Therapy Targeting the Somatostatin Receptor: Basic Principles, Clinical Applications and Optimization Strategies
por: Ahmadi Bidakhvidi, Niloefar, et al.
Publicado: (2021)

Human pancreatic cancer patients with Epithelial-to-Mesenchymal Transition and an aggressive phenotype show a disturbed balance in Protein Phosphatase Type 2A expression and functionality
por: van Pelt, Jos, et al.
Publicado: (2023)

Quantitative comparison of pre-treatment predictive and post-treatment measured dosimetry for selective internal radiation therapy using cone-beam CT for tumor and liver perfusion territory definition
por: Jafargholi Rangraz, Esmaeel, et al.
Publicado: (2020)

Change of telomerase activity in rectal cancer with chemoradiation therapy.
por: Kim, H. R., et al.
Publicado: (2000)

Johan Mackenbach, awarded an honorary doctorate for his work on health inequalities, in a discussion of burning issues in tackling health inequalities
por: Lorant, Vincent, et al.
Publicado: (2015)

A kernel-based integration of genome-wide data for clinical decision support
por: Daemen, Anneleen, et al.
Publicado: (2009)

Locally Advanced Colorectal Cancer: True Peritoneal Tumor Penetration is Associated with Peritoneal Metastases
por: Klaver, Charlotte E. L., et al.
Publicado: (2017)

Is evaluation by questionnaires sufficient to cover all aspects of bowel symptoms in rectal cancer patients after low anterior resection?
por: Asnong, Anne, et al.
Publicado: (2022)

Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter Study
por: Lambregts, Doenja M. J., et al.
Publicado: (2011)

Survival After Induction Chemotherapy and Chemoradiation Versus Chemoradiation and Adjuvant Chemotherapy for Locally Advanced Rectal Cancer
por: Kim, Jin K, et al.
Publicado: (2022)

Physical activity levels after low anterior resection for rectal cancer: one-year follow-up
por: Asnong, Anne, et al.
Publicado: (2021)

A phase I radiation dose-escalation study to determine the maximal dose of radiotherapy in combination with weekly gemcitabine in patients with locally advanced pancreatic adenocarcinoma
por: Budiharto, Tom, et al.
Publicado: (2008)

STARR with CONTOUR® TRANSTAR™ device for obstructed defecation syndrome: one-year real-world outcomes of the European TRANSTAR registry
por: Ribaric, G., et al.
Publicado: (2014)

Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety
por: Peponi, Evangelia, et al.
Publicado: (2015)

A randomized phase II study of capecitabine-based chemoradiation with or without bevacizumab in resectable locally advanced rectal cancer: clinical and biological features
por: Salazar, Ramon, et al.
Publicado: (2015)

Predictive Biomarkers to Chemoradiation in Locally Advanced Rectal Cancer
por: Conde-Muíño, Raquel, et al.
Publicado: (2015)

Clinical outcome of neoadjuvant chemoradiation in rectal cancer treatment
por: Suwanthanma, Weerapat, et al.
Publicado: (2021)

Randomised controlled trial to assess efficacy of pelvic floor muscle training on bowel symptoms after low anterior resection for rectal cancer: study protocol
por: Asnong, Anne, et al.
Publicado: (2021)

The use of deep learning on endoscopic images to assess the response of rectal cancer after chemoradiation
por: Haak, Hester E., et al.
Publicado: (2021)

Neoadjuvant chemoradiation therapy and pathological complete response in rectal cancer
por: Ferrari, Linda, et al.
Publicado: (2015)

Rectal tumor fragmentation as a response pattern following chemoradiation
por: Mills, Matthew N., et al.
Publicado: (2022)

Whole-body diffusion-weighted MRI for operability assessment in patients with colorectal cancer and peritoneal metastases
por: Dresen, Raphaëla Carmen, et al.
Publicado: (2019)

FANCD2 Mutation in a Patient With Early Rectal Cancer Receiving Definitive Chemoradiation
por: McDonald, Jordan, et al.
Publicado: (2021)

C‐reactive protein (CRP) trajectory as a predictor of anastomotic leakage after rectal cancer resection: A multicentre cohort study
por: Hoek, Vincent T., et al.
Publicado: (2021)

Transversus abdominis plane block versus perioperative intravenous lidocaine versus patient-controlled intravenous morphine for postoperative pain control after laparoscopic colorectal surgery: study protocol for a prospective, randomized, double-blind controlled clinical trial
por: Dewinter, Geertrui, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_52simimmf4sr60khq74a0qqpvk